Sanofi goes hostile in pursuit of Genzyme
October 04, 2010 at 04:48 AM EDT
French drug maker Sanofi-Aventis launches a hostile $18.5 billion bid for U.S biotech company Genzyme.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.